Industrial Microbiology Testing Services Market Share

North American Market Forecast

North America industry is estimated to dominate majority revenue share of 45% by 2037 impelled by the rising investment in the development of vaccines. This is expected to create a huge demand for industrial microbiology testing services in the region as it can be used to determine the quantity of microorganisms in a vaccination which often takes time since rigorous testing is necessary to make sure there are no unforeseen repercussions from them before distributing vaccines to the general public. For instance, for the development, manufacture, and acquisition of mRNA covid-19 vaccines, the US government spent more than USD 30 billion, before the pandemic until March 2022.

APAC Market Statistics

The APAC industrial microbiology testing services market is estimated to be the second largest, during the forecast timeframe led by the rising spending in healthcare. This has resulted in increasing spending research & development of reliable and efficient testing services to meet the rising need for quality control measures in the region. India spent over 1% of its GDP on healthcare in the year 2021.